growing

Infrastructure for Cancer Screening Program Management

AI system that identifies patients due for cancer screenings, manages outreach campaigns, and tracks screening completion and follow-up care.

Last updated: February 2026Data current as of: February 2026

Analysis based on CMC Framework: 730 capabilities, 560+ vendors, 7 industries.

T2·Workflow-level automation

Key Finding

Cancer Screening Program Management requires CMC Level 3 Formality for successful deployment. The typical utilization management & case management organization in Healthcare faces gaps in 5 of 6 infrastructure dimensions.

Structural Coherence Requirements

The structural coherence levels needed to deploy this capability.

Requirements are analytical estimates based on infrastructure analysis. Actual needs may vary by vendor and implementation.

Formality
L3
Capture
L3
Structure
L3
Accessibility
L3
Maintenance
L3
Integration
L3

Why These Levels

The reasoning behind each dimension requirement.

Formality: L3

Cancer screening program management requires explicitly documented eligibility criteria for each screening type—age windows, risk factor thresholds triggering earlier or more frequent screening, and payer quality measure specifications (HEDIS, UDS). When mammography eligibility is '40-74 annually or 50-74 biennially depending on payer' and that nuance lives only in the quality department's institutional knowledge, the AI cannot correctly identify which patients are due and under which protocol. Screening protocols must be current, findable, and linked to specific population definitions.

Capture: L3

Screening program management requires systematic capture of last screening exam dates, results, risk factors (family history, smoking pack-years), patient barriers (transportation, language), and outreach attempt outcomes. Template-driven capture of screening history and barrier assessments ensures the AI can correctly calculate when each patient is next due and personalize outreach. Outreach attempt outcomes—completed, declined, unreachable—must be logged to prevent duplicate contacts and track campaign effectiveness.

Structure: L3

Screening program management requires consistent schema: patient demographics fields, screening type codes, last screening date, result category (normal, abnormal, pending), risk factor indicators, barrier type codes, and outreach preference fields. Without standardized structure, the AI cannot systematically identify which patients are due for which screening under which protocol. Payer quality measure requirements must be structurally mapped to patient eligibility criteria to enable compliance tracking by measure.

Accessibility: L3

Cancer screening program management must access EHR for patient demographics and clinical history, scheduling systems for appointment availability, payer quality measure specifications, and communication platforms for outreach. API access to the EHR enables automated identification of eligible patients without manual cohort extraction. For navigation workflow triggers on positive results, the system must access EHR result data and route alerts to the appropriate navigator. External facility screening data remains a gap per HIE limitations in the baseline.

Maintenance: L3

Cancer screening eligibility criteria update when USPSTF issues guideline revisions, when CMS updates quality measure specifications, and when individual payer contracts change HEDIS measure thresholds. The AI's patient identification logic must reflect current guidelines—event-triggered updates when USPSTF revises lung cancer screening age criteria ensure the system immediately expands the eligible population rather than waiting for quarterly review. Payer-specific quality measure specifications require contract-change-triggered updates.

Integration: L3

Cancer screening program management requires integration between EHR (patient demographics, clinical history, results), scheduling systems (appointment booking), communication platforms (outreach campaigns), and quality measure reporting. The baseline confirms EHR integration and UM software connectivity. API-based connections enable the screening AI to push patient lists to outreach platforms, trigger navigator workflows on positive results, and pull appointment completion confirmations back for quality measure tracking. Community resource and transportation integration remains limited per baseline HIE constraints.

What Must Be In Place

Concrete structural preconditions — what must exist before this capability operates reliably.

Primary Structural Lever

How explicitly business rules and processes are documented

The structural lever that most constrains deployment of this capability.

How explicitly business rules and processes are documented

  • Documented screening eligibility protocols per cancer type (colorectal, breast, cervical, lung) with age, risk-factor, and interval criteria codified in structured decision rules

Whether operational knowledge is systematically recorded

  • Systematic capture of screening completion events, outreach touchpoint outcomes, and patient refusal reasons into a longitudinal screening registry

How data is organized into queryable, relational formats

  • Unified patient data schema linking primary care records, lab results, imaging orders, and outreach history to enable cohort identification across screening types

Whether systems expose data through programmatic interfaces

  • Governance framework defining which screening recommendation updates the AI may action autonomously versus which require physician sign-off

How frequently and reliably information is kept current

  • Scheduled review cycle that compares actual screening completion rates against program targets and updates outreach suppression lists when patient status changes

Whether systems share data bidirectionally

  • Bidirectional integration between the AI platform, the EHR scheduling module, and the patient outreach communication layer to confirm appointments and record outcomes

Common Misdiagnosis

Programs invest in outreach automation before establishing a reliable screening registry — the AI then contacts patients already screened elsewhere, eroding trust and inflating false-positive outreach rates.

Recommended Sequence

Start with formalizing eligibility and interval rules per cancer type because outreach cohort logic cannot be computed correctly until inclusion and exclusion criteria are structurally encoded.

Gap from Utilization Management & Case Management Capacity Profile

How the typical utilization management & case management function compares to what this capability requires.

Utilization Management & Case Management Capacity Profile
Required Capacity
Formality
L3
L3
READY
Capture
L2
L3
STRETCH
Structure
L2
L3
STRETCH
Accessibility
L2
L3
STRETCH
Maintenance
L2
L3
STRETCH
Integration
L2
L3
STRETCH

Vendor Solutions

5 vendors offering this capability.

More in Utilization Management & Case Management

Frequently Asked Questions

What infrastructure does Cancer Screening Program Management need?

Cancer Screening Program Management requires the following CMC levels: Formality L3, Capture L3, Structure L3, Accessibility L3, Maintenance L3, Integration L3. These represent minimum organizational infrastructure for successful deployment.

Which industries are ready for Cancer Screening Program Management?

Based on CMC analysis, the typical Healthcare utilization management & case management organization is not structurally blocked from deploying Cancer Screening Program Management. 5 dimensions require work.

Ready to Deploy Cancer Screening Program Management?

Check what your infrastructure can support. Add to your path and build your roadmap.